Eco Animal Health Group (LON:EAH)‘s stock had its “buy” rating reissued by investment analysts at Peel Hunt in a research report issued to clients and investors on Monday, ThisIsMoney.Co.Uk reports.

LON EAH opened at GBX 430 ($5.62) on Monday. The company has a market capitalization of $290.01 million and a price-to-earnings ratio of 28.48. Eco Animal Health Group has a 12-month low of GBX 255 ($3.33) and a 12-month high of GBX 755 ($9.87).

In other news, insider Julia Trouse sold 75,000 shares of the stock in a transaction on Thursday, February 7th. The shares were sold at an average price of GBX 485 ($6.34), for a total transaction of £363,750 ($475,303.80).

Eco Animal Health Group Company Profile

ECO Animal Health Group plc develops and markets pharmaceutical products for animals worldwide. The company offers Aivlosin, a macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry. It also provides generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.

Read More: How does inflation affect different investments?

Receive News & Ratings for Eco Animal Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eco Animal Health Group and related companies with MarketBeat.com's FREE daily email newsletter.